Skip to main content
FinSpry Logo
FinSpry
PSTV logo
PSTV
(NASDAQ)
Plus Therapeutics, Inc.
$3.56-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Plus Therapeutics (PSTV) Stock Price & Financial Analysis

Plus Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.30 - $3.81
52-Week High$15.33
52-Week Low$0.16
Open$3.75
Volume578.19K
Average Volume (3M)578.19K
Market Cap382.45M
Shares Outstanding107.43M
Price to Sales (P/S)79.58
Price to Book (P/B)82.79
EV/EBITDA-20.76
Revenue (TTM)5.26M
Net Income (TTM)-20.58M
Free Cash Flow (TTM)-15.78M
EPS (TTM)$-0.19
Profit Margin-391.33%
Operating Margin-255.91%
Return on Equity (ROE)-407.12%
Debt to Equity0.01
50-Day MA$6.56
200-Day MA$2.70
52-Week Change281.86%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Plus Therapeutics

What is the current stock price for PSTV?

As of the latest trading session, PSTV stock trades at $3.56. The 52-week range is $0.16–$15.33, with a day range of $3.30–$3.81.

What is the P/E ratio for PSTV?

The P/E ratio (Price-to-Earnings) for PSTV is shown in the Key Statistics section. This valuation metric helps compare Plus Therapeutics, Inc. to industry peers.

Does PSTV pay dividends?

Plus Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PSTV?

Based on 2 analysts, the consensus for PSTV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PSTV?

Plus Therapeutics's market capitalization is $382.4M, classifying it as a small-cap company. Plus Therapeutics operates in the Healthcare sector within the Biotechnology industry.